The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-((Dimethylamino)methyl)-N-(3-(6-(3-(pyrrolidin-1-yl)propoxy)benzo[d]oxazol-2-yl)phenyl)benzamide ID: ALA4100657
PubChem CID: 137661216
Max Phase: Preclinical
Molecular Formula: C30H34N4O3
Molecular Weight: 498.63
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CN(C)Cc1ccc(C(=O)Nc2cccc(-c3nc4ccc(OCCCN5CCCC5)cc4o3)c2)cc1
Standard InChI: InChI=1S/C30H34N4O3/c1-33(2)21-22-9-11-23(12-10-22)29(35)31-25-8-5-7-24(19-25)30-32-27-14-13-26(20-28(27)37-30)36-18-6-17-34-15-3-4-16-34/h5,7-14,19-20H,3-4,6,15-18,21H2,1-2H3,(H,31,35)
Standard InChI Key: MYKNCJPLMJTHDR-UHFFFAOYSA-N
Molfile:
RDKit 2D
37 41 0 0 0 0 0 0 0 0999 V2000
15.6307 -14.5315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0393 -13.8208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6307 -13.1143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0393 -12.4036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8565 -12.4036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2651 -13.1143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8565 -13.8208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0393 -15.2339 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.8135 -14.5315 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.4049 -13.8208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5877 -13.8208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1791 -13.1143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5877 -12.4036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4049 -12.4036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8135 -13.1143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8859 -13.7758 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.3619 -13.1143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8859 -12.4486 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.1046 -12.7057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1046 -13.5229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3996 -13.9315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6905 -13.5229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6905 -12.7057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3996 -12.2971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9814 -13.9315 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.2765 -13.5229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5674 -13.9315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8583 -13.5229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1533 -13.9315 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.0652 -14.7389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2668 -14.9149 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8582 -14.2042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4060 -13.5972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2651 -11.6970 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0823 -11.6970 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.4909 -10.9946 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4909 -12.4036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
2 7 2 0
1 8 2 0
1 9 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
10 15 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 1 0
16 20 1 0
21 22 1 0
22 23 2 0
23 24 1 0
19 24 2 0
20 21 2 0
26 27 1 0
27 28 1 0
25 26 1 0
29 30 1 0
30 31 1 0
31 32 1 0
32 33 1 0
29 33 1 0
28 29 1 0
22 25 1 0
12 17 1 0
9 10 1 0
35 36 1 0
35 37 1 0
34 35 1 0
5 34 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 498.63Molecular Weight (Monoisotopic): 498.2631AlogP: 5.67#Rotatable Bonds: 10Polar Surface Area: 70.84Molecular Species: BASEHBA: 6HBD: 1#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 9.33CX LogP: 4.70CX LogD: 1.73Aromatic Rings: 4Heavy Atoms: 37QED Weighted: 0.28Np Likeness Score: -1.80
References 1. Roy S, Mukherjee A, Paul B, Rahaman O, Roy S, Maithri G, Ramya B, Pal S, Ganguly D, Talukdar A.. (2017) Design and development of benzoxazole derivatives with toll-like receptor 9 antagonism., 134 [PMID:28437629 ] [10.1016/j.ejmech.2017.03.086 ] 2. Pal S, Paul B, Bandopadhyay P, Preethy N, Sarkar D, Rahaman O, Goon S, Roy S, Ganguly D, Talukdar A.. (2021) Synthesis and characterization of new potent TLR7 antagonists based on analysis of the binding mode using biomolecular simulations., 210 [PMID:33189437 ] [10.1016/j.ejmech.2020.112978 ]